378 related articles for article (PubMed ID: 27121324)
1. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
Xu YD; Shang J; Li M; Zhang YY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
Zhang X; Bo P; Liu L; Zhang X; Li J
Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
12. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
14. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
[TBL] [Abstract][Full Text] [Related]
17. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.
Wang Y; Zhang D; Wu K; Zhao Q; Nie Y; Fan D
Mol Cell Biol; 2014 Sep; 34(17):3182-93. PubMed ID: 24958102
[TBL] [Abstract][Full Text] [Related]
19. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
20. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression.
Hang Q; Sun R; Jiang C; Li Y
Anticancer Drugs; 2015 Jul; 26(6):632-40. PubMed ID: 25763542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
